Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vitae Pharmaceuticals, Inc (VTAE) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Vitae Pharmaceuticals, Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1157602.
Total stock buying since 2014: $24,617,846.
Total stock sales since 2014: $23,719,091.
Total stock option exercises since 2014: $1,988,662.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2016 | 0 | $0 | 1,091,130 | $22,531,433 | 140,032 | $1,106,336 |
| 2015 | 10,000 | $78,270 | 74,784 | $1,187,658 | 249,090 | $882,326 |
| 2014 | 3,067,447 | $24,539,576 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2016-10 | 0 | $0 | 0 | $0 | 123,902 | $1,050,688 |
| 2016-09 | 0 | $0 | 1,075,000 | $22,411,749 | 0 | $0 |
| 2016-03 | 0 | $0 | 16,130 | $119,684 | 16,130 | $55,648 |
| 2015-12 | 0 | $0 | 38,654 | $673,248 | 65,191 | $224,907 |
| 2015-11 | 0 | $0 | 0 | $0 | 100,557 | $478,478 |
| 2015-09 | 0 | $0 | 16,130 | $274,210 | 16,130 | $55,648 |
| 2015-08 | 10,000 | $78,270 | 0 | $0 | 0 | $0 |
| 2015-05 | 0 | $0 | 20,000 | $240,200 | 20,000 | $69,000 |
| 2015-03 | 0 | $0 | 0 | $0 | 8,115 | $9,332 |
| 2015-01 | 0 | $0 | 0 | $0 | 39,097 | $44,961 |
| 2014-09 | 3,067,447 | $24,539,576 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-10-19 | Gregg Richard (Chief Science Officer) | Option Ex | 123,902 | 8.48 | 1,050,688 |
| 2016-09-14 | Hatfield Jeffrey S. (Chief Executive Officer) | Sale | 50,000 | 20.81 | 1,040,499 |
| 2016-09-14 | Gross Phillip | Sale | 1,025,000 | 20.85 | 21,371,250 |
| 2016-03-21 | Hayden Donald J Jr (Director) | Sale | 16,130 | 7.42 | 119,684 |
| 2016-03-21 | Hayden Donald J Jr (Director) | Option Ex | 16,130 | 3.45 | 55,648 |
| 2015-12-29 | Hayden Donald J Jr (Director) | Sale | 16,130 | 18.00 | 290,340 |
| 2015-12-29 | Hayden Donald J Jr (Director) | Option Ex | 16,130 | 3.45 | 55,648 |
| 2015-12-28 | Hatfield Jeffrey S. (Chief Executive Officer) | Option Ex | 26,537 | 3.45 | 91,552 |
| 2015-12-23 | Hatfield Jeffrey S. (Chief Executive Officer) | Sale | 22,524 | 17.00 | 382,908 |
| 2015-12-23 | Hatfield Jeffrey S. (Chief Executive Officer) | Option Ex | 22,524 | 3.45 | 77,707 |
| 2015-11-16 | Gregg Richard (Chief Science Officer) | Option Ex | 15,000 | 3.91 | 58,650 |
| 2015-11-13 | Gregg Richard (Chief Science Officer) | Option Ex | 85,557 | 4.91 | 419,828 |
| 2015-09-21 | Hayden Donald J Jr (Director) | Sale | 16,130 | 17.00 | 274,210 |
| 2015-09-21 | Hayden Donald J Jr (Director) | Option Ex | 16,130 | 3.45 | 55,648 |
| 2015-08-27 | Fratamico Arthur (Chief Business Officer) | Buy | 10,000 | 7.83 | 78,270 |
| 2015-05-20 | Hayden Donald J Jr (Director) | Sale | 20,000 | 12.01 | 240,200 |
| 2015-05-20 | Hayden Donald J Jr (Director) | Option Ex | 20,000 | 3.45 | 69,000 |
| 2015-03-06 | Hatfield Jeffrey S. (Chief Executive Officer) | Option Ex | 8,115 | 1.15 | 9,332 |
| 2015-01-22 | Hatfield Jeffrey S. (Chief Executive Officer) | Option Ex | 39,097 | 1.15 | 44,961 |
| 2014-09-29 | Barrett Peter (Director) | Buy | 37,500 | 8.00 | 300,000 |
| 2014-09-29 | Vef Management Iii Llc (10% Owner) | Buy | 772,333 | 8.00 | 6,178,664 |
| 2014-09-29 | Roberts Bryan E (Director) | Buy | 772,333 | 8.00 | 6,178,664 |
| 2014-09-29 | Sandell Scott D (10% Owner) | Buy | 813,474 | 8.00 | 6,507,792 |
| 2014-09-29 | Prospect Venture Partners Ii Lp (10% Owner) | Buy | 671,807 | 8.00 | 5,374,456 |
Insider trading activities including stock purchases, stock sales, and option exercises of VTAE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Vitae Pharmaceuticals, Inc (symbol VTAE, CIK number 1157602) see the Securities and Exchange Commission (SEC) website.